Medical genetics Books

Book SynopsisIn this book, the authors present new research in the study of sex chromosomes. Topics discussed in this compilation include the evolution of mammalian X chromosomes and X chromosome inactivation; the role of sex chromosomes in mammalian female fertility; the fate of the Y chromosome; the role of Y chromosome genes on tumour development risk in disgenetic gonads; deletion of amelogenin Y-locus; non-invasive prenatal diagnosis for foetal sex determination; and application of X chromosomal STR polymorphisms to individual identification.

Read more less

Book SynopsisEnzymes are necessary for nearly all of life''s chemical reactions. With the advance of biotechnology, increasing numbers of enzymes are identified and over-produced prior to application in various industries that encompass medicine, agro-industry, commodity products sectors, and biofuel biotechnologies. Many enzymes currently are derived from recombinant micro-organisms. Enzyme manufacturers take advantage of new genetic techniques to develop and manufacture enzymes with improved properties. Such enzymes often originate from micro-organisms that cannot be readily cultured under laboratory or industrial conditions. By judicious selection of host micro-organisms, recombinant production strains can be constructed to allow efficient production of enzymes that are substantially free of undesirable enzymes or other microbial metabolites. The developments in molecular genetics and cell biology in the last four decades have reshaped enzyme production. This book provides comprehensive material on applications of important microbes and their gene functions in enzyme technology for audiences across many disciplines.

Read more less

Book SynopsisEmotion is among the most relevant factors of human life, and it exerts a deep influence on all aspects of our lives and behaviour. However, little is known about emotional processing or regulation and experience of emotions under an atypical human condition like Down syndrome (DS). This book represents an initial effort to integrate the most important findings regarding the study of emotion on DS from a cognitive point of view. The first part of this book is focused on general aspects of DS. Mainly, the human nature of persons with Down syndrome is highlighted beyond the intellectual disability that is associated to this genetic condition. Furthermore, the second part of the book, thoroughly describes specific details of cognitive-emotional mechanisms underlying the affective life of DS. Moreover, it is emphasised how neuro-architecture aspects related to DS condition typify the emotional human nature of this population. The third part of the book is concerned with cognitive research advances in the study of emotion and DS. Specifically, findings related to emotion face recognition as well as appraisal processes underlying love judgements on DS are discussed from an experimental approach. Finally, future implications and directions on emotion research on Down syndrome are presented.

Read more less

Book SynopsisAn oncogene is a modified gene, or a series of nucleotides that encode a protein, and direct the cell to the development of a neoplastic phenotype. Usually, oncogenes are involved in tumour development and increase the possibility that the development of a cell directs towards cancer. In this book, the authors present current research in the study of the classification, mechanisms of activation and role in cancer development of oncogenes. Topics include the role of oncogenes in gynaecological pathology; oncomirs as the next frontier of oncogenes affecting cancer aetiology and tumour progression; the role of the epidermal growth factor receptor as a therapeutic target in glioblastoma and other malignancies; and tumour suppressers involved in DNA repair and carcinoprevention.

Read more less

Book SynopsisHow a journey of self-discovery unearthed the scandalous evolution of artificial insemination. By his forties, Peter J. Boni was an accomplished CEO, with a specialty in navigating high-tech companies out of hot water. Just before his fiftieth birthday, Peter’s seventy-five-year-old mother unveiled a bombshell: His deceased father was not biological. Peter was conceived in 1945 via an anonymous sperm donor. The emotional upheaval upon learning that he was “misattributed” rekindled traumas long past and fueled his relentless research to find his genealogy. Over two decades, he gained an encyclopedic knowledge of the scientific, legal, and sociological history of reproductive technology as well as its practices, advances, and consequences. Through twenty-first century DNA analysis, Peter finally quenched his thirst for his origin. In Uprooted, Peter J. Boni intimately shares his personal odyssey and acquired expertise to spotlight the free market methods of gamete distribution that conceives dozens, sometimes hundreds, of unknowing half-siblings from a single donor. This thought-provoking book reveals the inner workings—and secrets—of the multibillion-dollar fertility industry, resulting in a richly detailed account of an ethical aspect of reproductive science that, until now, has not been so thoroughly explored.

Read more less

Book SynopsisAlternative splicing occurs in most human genes and contributes to protein diversity by producing multiple mRNAs from each gene. In this book, the authors present new developments in alternative splicing research. Topics discussed include alternative splicing alterations in Alzheimer''s disease; plant RNA-binding proteins implicate mRNA processing in abscisic acid (ABA) responses; comprehensive analyses of alternative exons in neuronally differentiated P19 cells; an epigenetic view on alternative splicing; identification of genuine alternative splicing variants for rare or long-sized transcripts; alternative RNA splicing and regulation of nitric oxide signalling; alternative splicing by analysing human mRNA diversity using data of FLJ human cDNAs; alternative splicing in human immune systems and auto-immune diseases; and poly (ADP-Ribosyl)ation regulation in alternative splicing.

Read more less

Book SynopsisViral diseases have an important impact on public health world-wide. New genomic technologies are providing infectious disease scientists with a unique ability to study at the genetic level those viruses that cause disease and the interactions they have with infected hosts. In this book, the authors present new research in viral genomes. Topics include improvements in HSV-1 derived amplicon vectors for gene transfer; viral genome research in papillomavirus; the synthetic synthesis of viral genomes; and a novel bioinformatic method to analyse over 10,000 influenza virus strains simultaneously.

Read more less

Book SynopsisAutosomal dominant inheritance means an abnormal gene from one parent can cause disease, even though the matching gene from the other parent is normal. The abnormal gene dominates. In this book, the authors present new research in autosomal dominant disorders. Topics discussed include the pathophysiology and treatment of autosomal polycystic kidney disease; hereditary haemorrhagic telangiectasia or Rendu-Osler-Weber Syndrome; osteogenesis imperfecta; and autosomal dominant disorders associated with breast cancer.

Read more less

Book SynopsisThe sequencing of the human genome was a pivotal event in science that opened the door to exploring the structure and function of genes and their regulation. The activation or suppression of transcribed genes is critical to the orchestration of everyday biological processes at the cellular, tissue, and physiological levels. The rapid advance of science and technology has yielded the development of the microarray technique, which has propelled a much deeper understanding of the genome. By combining these technological advances in microarrays with statistical and bioinformatics software, investigators are now able to perform scientific investigations geared towards answering unique biological problems that encompass many fields of research from genetics and evolution to molecular medicine, health, and disease. This book provides an overview of the use and application of microarrays throughout the life sciences to address diverse complex biological questions. In this collection, authors present information on using microarrays to unlock molecular mechanisms and gene expression patterns associated with research areas ranging from biodefense, pathological changes, and monitoring antimicrobial resistance genes to diagnostics, marine biodiversity, and dermal toxicology.

Read more less

Book SynopsisChronic pancreatitis (CP), a worldwide disease, is primarily recognised as a long-standing inflammation of the pancreas that alters the organ''s normal structure and functions. CP reflects the end-stage pathology of inflammation-associated diseases. It presents episodes of acute inflammation or chronic damage of pancreas with symptoms of persistent abdominal pain or malabsorption, weight loss, pain related to the intake of food containing a high percentage of fats and protein. The health conditions of diabetics have been found to deteriorate due to pancreatic damage in CP. A plethora of information has emerged in recent years in the area of pancreatitis research. The frontiers of current pancreatic research reflected its newer definitions, classifications, tools for investigations, animal models, insight into the molecular mechanisms of the initiation of the earliest pancreatic injury, the role of cytokines and inflammation; and attributes of genetic mutations in SPINK1 CFTR, CTSB, MTHFR and ACE etc. during pancreatitis. The topological variations of patients have been found to be associated to a different trend of pathogenesis and severity of the disease, which might be associated to relatively poor nutritional uptake and other environmental factors. Keeping these facts in view, we envisaged to bring out an updated overview on this subject in general and to present the experiment based information on tropical chronic pancreatitis (TCP) in the patients from northern part of India in particular.

Read more less

Book SynopsisThe FMR1 gene is an example of how a single gene can have different phenotypic effects. Indeed, since its discovery in 1991 it has revealed new facets: classic Fragile X syndrome (FXS), Fragile X premature ovarian insufficiency (FXPOI), Fragile X tremor-ataxia syndrome (FXTAS) and other emerging disorders from which we are continuously learning more about this gene. The chapters of this book provide an update of the different allelic forms of the FMR1 gene. Chapter 1 is a description of the classical Fragile X syndrome including clinical findings in males and females, the FMR1 gene, molecular bases, the FMRP protein, animal models, genetic counselling, new-born screening and diagnosis. Chapters 2 and 3 review the two main disorders associated with FMR1 premutation: FXPOI and FXTAS. FXPOI is a new clinical entity in which carrier premutation (PM) females present early ovarian dysfunction, with menopause occurring 5 years earlier than non-carrier family members. FXTAS is a late-onset inherited neuropsychiatric degenerative disorder that occurs predominantly in male carriers of the FMR1 premutation. Chapters 4 and 5 present the most recent advances in the current knowledge of other disorders associated with the FMR1 gene: Chapter 4 describes the psychopathological alterations of the different phenotypes associated with either premutation or full mutation. Chapter 5 is focused on the pathologies associated with the premutation such as fibromyalgia, thyroid disease and hypertension, among others. A comprehensive review of genetic counselling is done in Chapter 6 including all types of alleles related to the FMR1 gene and point mutations. Finally, although at present there is no treatment for any of these pathologies, an update of the clinical trials on therapies for all these FMR1 gene-related disorders and their current status is made in Chapter 7.

Read more less

Book SynopsisIn this book, mathematical aspects of a population genetics are considered. On the basis of the Hardy - Weinberg law, the standard approach to population genetics problems is stated. Along with the standard approach, the necessity of separate research of family tree genetics and population genetics, which represent set of the family trees, is shown. Family trees are investigated by methods of discrete mathematics in a discrete time scale which is defined by alternation of generations. It is necessary to transit to a continuous time scale, continuous functions, therefore the Hardy-Weinberg law is written down in the form of the differential equation of the second order. Transition to continuous functions has allowed us to receive new and certainly not trivial results in population genetics. In particular, a new approach to problems of a mutations occurrence under radiation is discussed, of a new growths occurrence, and migrations of populations under various conditions to reveal nonlinear character of inbreeding and natural selection. The book can be useful to geneticists, students-biologists, post-graduate students and everyone who is interested in problems of population genetics.

Read more less

Book Synopsis"Advances in Genetics Research" presents original research results on the leading edge of genetics discovery. Each article has been carefully selected in an attempt to present substantial research results across a broad spectrum. In this continuing series compilation, the authors present and discuss mitochondrial gene diversity of the mega-herbivorous species of the genus Tapirus (tapiridae, perissodactyla) in South America and some insights on their genetics conservation, systematics and the pleistocene influence on their genetic characteristics; strategies for gene prospecting of plants in response to drought and salinity; clinical evidence and the genetic effects of traditional Chinese medicine for the management of proteinuria in patients with diabetic nephropathy; biochemistry and genetics of ansamycin antibiotics; BRCA gene mutations mediate particularly high TNBC risk by defective estrogen signaling; genotype-phenotype relationships in language processes in Rett syndrome; Marfan syndrome; Marfan syndrome and periodontitis; combined pectus correction and aortic valve sparing root replacement in Marfan patients; severe periodontitis in Marfan syndrome; and preimplantation genetic diagnosis for Marfan syndrome.

Read more less

Book SynopsisIn the human body, collagen is the most abundant structural protein, forming up to 35% of the entire protein content of the whole body. In this book, the preparation, characterization and applications in tissue regeneration of bovine type 1 collagen are reviewed. Furthermore, collagen is often used in regenerative medicine. In this book, the authors report on the helicity of collagen molecule in fibrils by circular dichroism spectroscopy and the thermograph of fibrils by differential scanning calorimetry (the structural aspects of collagen molecules). In the last chapter, second harmonic generation (SHG) microscopy is reviewed and its potential to visualize collagen fibers in a variety of connective tissues.

Read more less

Book Synopsis"Advances in Genetics Research" presents original research results on the leading edge of genetics discovery. Each article has been carefully selected in an attempt to present substantial research results across a broad spectrum. In this continuing series compilation, the authors present and discuss patent roadmap for the biosensor space; avoidant/restrictive food intake disorder in a female patient affected by Marfan syndrome; optimising oil production in B. napus by gene stacking; periodontitis; genomic imprinting and the brain: neuron-specific switching of gene expression at imprinting regions; and pharmacogenomics focusing on phase two metabolising enzymes.

Read more less

Book Synopsis"Advances in Genetics Research" presents original research results on the leading edge of genetics discovery. Each article has been carefully selected in an attempt to present substantial research results across a broad spectrum. In this continuing series compilation, the authors present and discuss the most recent Y chromosome progress within the main fields of genetics; male infertility associated with TTTY gene family deletions in the Y chromosome; genetic diversity assessment by random amplified polymorphic DNA; the effect of habitat fragmentation on genetic diversity; the use of HeLa cells as a model for studying DNA damage and repair; the molecular genetics of polycythemia vera; recent advances and molecular background of microRNAs in disease; papaya viral diseases; phylogenetics and phylogeography of large neotropical rodents by means of mitochondrial genes; and omics technologies applied to prokaryotes.

Read more less

Book SynopsisEpigenetics is a relatively new field of science explaining heritable changes that are not caused by alterations in DNA sequences. Epigenetic modifications are acquired throughout life, and depend on environmental clues such as diet, lifestyle and toxin exposure. It is possible to pass down epigenetic modifications to the next generation of offspring if the modifications occur in sperm or egg cells. Additionally, epigenetic regulations are central to many cellular processes such as imprinting, X chromosome inactivation, DNA damage response, cellular reprogramming and senescence. This book provides an overview for the influence of early life nutrition on the epigenome and the role of epigenetic dysregulations in the pathogenesis of many common diseases.

Read more less

Book SynopsisThe study of autism development disorders has been dominated by the neurodevelopmental paradigm for almost 50 years. This book challenges the exclusivity of the neurodevelopmental paradigm by using unique population cohort data to study recurrence risk of ASD in Israel. Randomness in the timing of ASD diagnoses of index children is exploited, as in a natural experiment, to randomise within-group reproductive stoppage. Some parents of children on the spectrum consciously refrained from reproductive stoppage by having further children. Other parents had further children before their index child was diagnosed. The former parents raised their further children having gained experience in raising children on the spectrum. The latter parents raised their children under a veil of ignorance, to be broken when their index children were diagnosed. Whereas neurodevelopmental theory predicts that recurrence risk is the same for both types of parents, behavioural theory predicts that they should be different. Population cohort data for Israel corroborate the predictions of behavioural theory. Indeed, corroboration applies in four different tests. More generally, the author calls for a level playing field in which behavioural theory of recurrence risk is placed on an equal footing as the dominant neurodevelopmental paradigm. He also argues for methodological pluralism in which the epidemiological toolbox is augmented with methods from statistics and econometrics. In summary, the author offers a critique of the current state of research on recurrence risk of ASD.Table of ContentsPreface; Recurrence Risk; Recurrence Risk Theory; Methodology for Recurrence Risk; Empirical Estimates of Recurrence Risk; Population Cohort Data for Israel; Within-group Reproductive Stoppage in Israel; Behavioral Influences on Recurrence Risk; Selection Bias Induced by Reproductive Stoppage in Estimates of Recurrence Risk for Autism Spectrum Disorders; What Have We Learned About Recurrence Risk?; The Transition into Adulthood with Autism Spectrum Disorders; Index.

Read more less

Book SynopsisEpigenetics, which deals with the study of heritable gene expression that takes place independent of changes in DNA sequence, and optogenetics, which deals with the study of genes expressed under the influence of light, are two emerging areas of study and research that have contributed immensely to our current knowledge of mechanisms and disease processes in humans. These disciplines are interrelated in the broader picture of biology and one can be used to change or modify the other. The complexity of the techniques involved in these disciplines often leads to a lack of proper understanding by researchers from other disciplines and the scientific community at large. As such, this book provides simple and easy-to-follow explanations of some of the most exciting areas of research in these disciplines.

Read more less

Book SynopsisThis work which was published to mark the tenth anniversary of the collaboration between the Institut Pasteur and the Riken Institute in Japan, covers a number of research fields in which both laboratories are active: precocious development in mice and the effect on them of disactivating genes, nuclear oncogenes and their role in controlling cell division, and the molecular bases of bacterial and viral infections. There are also chapters dealing with specific aspects of immune recognition, the genetics of sexual determination in humans and a new technique for studying the human genome. This book is intended for researchers and physicians in the fields of immunology, genetics, bacteriology/virology, cancerology, developmental biology, cellular biology and neurobiology.

Read more less

Book Synopsis"In this timely study, Jean Buttigieg demonstrates the necessity to make it a legal principle of international law that the human genome is a common heritage of mankind. In 1997, the UNESCO General Conference declared the human genome a common heritage of humankind. This declaration was followed by the Joint Statement of March 14, 2000, by US President Bill Clinton and British Prime Minister Tony Blair, in which they stated that the fundamental data on the human genome, including the human DNA sequence and its variations, should be made freely available to scientists everywhere. This announcement to allow unencumbered access to this fundamental data on the human genome, for the benefit of all humanity, appeared to endorse the UNESCO Declaration of 1997 on the human genome. But as it turns out, these statements were only political slogans since there is a complete lack of any genuine attempts to make the human genome a legal principle of international law so far. This study's foremost goal is to re-introduce the philosophical and political implications of the concept of common heritage of mankind into public discourse, as intended by Arvid Pardo when he addressed the UN General Assembly on November 1, 1967, and apply them to the human genome. As Buttigieg demonstrates, the biggest challenge here comes from the patent system in its present form, which encourages the commercialization of the human genome by explicitly denying scientists unencumbered access to the fundamental raw data. By putting individual rights before community rights, the patent system effectively hinders discoveries that prompt new and better medical treatments. Buttigieg also discusses issues of biotechnology. While the biotechnology debate is very often centred on which new applications of biotechnology should or should not be permitted, it so far lacks a critical philosophical analysis of biotechnology itself. The true essence of the human genome, Buttigieg argues, is to be found in metaphysics and not biology. This study fills a gap in the literature on the human genome and the common heritage of mankind by addressing the metaphysical nature of the human genome and discussing the philosophical concerns surrounding the field of biotechnology."

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisThe definitive guide to genetic bone disorders, now revised and expanded with glossy photographs and radiographsBrilliantly written and produced and deserves to be on the shelves of all pediatric radiologists. It should also be available to geneticists, counselors, and pediatricians. --Radiology This updated and expanded fourth edition of Bone Dysplasias presents age-related radiographs, photographs and clinical guidelines for more than 250 rare constitutional skeletal diseases. Focusing on diagnostically essential imaging and clinical features, each chapter is supplemented with prognostic and therapeutic information, a guide to differential diagnoses, and a short list of the most relevant publications. Organized in accordance with the most recent International Nosology and Classification of Genetic Skeletal Disorders, this new Bone Dysplasias distills the insights of a small, world-class author team on diagnosis and clinical approaches to this most difficult class of disorders.Trade ReviewNo books come to mind for comparison. This is a unique and high-quality publication that should be considered essential for teaching and practicing medical genetics. * Luis F Escobar, Doodys *Table of ContentsForeword John M. Opitz Preface 1. Achondroplasia AND Related FGFR3 Conditions 1.1 Thanatophoric Dysplasia, Types 1 and 2 (MIM 187600, 187601) 1.2 ACHONDROPLASIA (MIM 100800) 1.3 Hypochondroplasia (MIM 146000) 1.4 SADDAN (Severe Achondroplasia with Developmental Delay and Acanthosis Nigricans) (MIM 616482) 2. PSEUDOACHONDROPLASIA AND DOMINANT EPIPHYSEAL DYSPLASIA 2.1 Pseudoachondroplasia (MIM 177170) 2.2 MULTIPLE EPIPHYSEAL DYSPLASIAS, AUTOSOMAL DOMINANT (MIM 132400, 614135, 600204, 600969, 607078) 3. 3.1 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE (MIM 156500) 3.2 Cartilage-Hair Hypoplasia (MIM 250250) 3.3 Metaphyseal Dysplasia, Spahr Type (MIM 250400) 3.4 Metaphyseal Anadysplasia (MIM 602111, 613073) 3.5 SHWACHMAN SYNDROME (MIM 260400) 3.6 Metaphyseal Chondrodysplasia, Jansen Type (MIM 156400) 3.7 EIKEN DYSPLASIA (MIM 600002) 3.8 CINCA (Chronic Infantile Neurologic Cutaneous and Articular Syndrome) (MIM 607115) 4. 4.1 Achondrogenesis II, Hypochondrogenesis (MIM 200610) 4.2 Platyspondylic Dysplasia, Torrance Type (MIM 151210) 4.3 Spondyloepiphyseal Dysplasia Congenita (MIM 183900) 4.4 Spondylo-epi-metaphyseal Dysplasia, Strudwick type (MIM 183900, 184250, 184253) 4.5 KNIEST DYSPLASIA (MIM 156550) 4.6 spondyloepiphyseal Dysplasia, stanescu type (MIM 616538) 4.7 Spondyloperipheral Dysplasia (MIM 271700) 4.8 Spondyloepiphyseal Dysplasia with short metatarsals (MIM 609162) 4.9 Stickler Dysplasia (MIM 108300, 604841) 4.10 Fibrochondrogenesis (MIM 228520) 4.11 Oto-Spondylo-Megaepiphyseal Dysplasia (MIM 184840, 277610, 215150) 5. Mucopolysaccharidoses and Oligosaccharidoses 5.1 Dysostosis multiplex 5.2 Mucopolysaccharidosis IV (MIM 253000, 253010) 5.3 MUCOLIPIDOSIS II (MIM 252500) 5.4 MUCOLIPIDOSIS III (MIM 252600, 252605) 6. Metatropic Dysplasia and Other TRPV4-related Skeletal Dysplasias 6.1 Metatropic Dysplasia (MIM 156530, 168400) 6.2 Spondyloepiphyseal Dysplasia, Maroteaux Type (MIM 184095) 6.3 Spondylometaphyseal Dysplasia, Kozlowski Type (MIM 184252) 6.4 Brachyolmia, autosomal dominant (MIM 113500) 6.5 Familial Digital Arthropathy with Brachydactyly(MIM 606835) 7. 7.1 Achondrogenesis type 1A (MIM 200600) 7.2 ODONTOCHONDRODYSPLASIA (MIM 184260) 7.3 Schneckenbecken Dysplasia (MIM 269250) 7.4 OPSISMODYSPLASIA (MIM 258480) 7.5 Spondylometaphyseal dysplasia - Sedaghatian type. (MIM 250220) 7.6 Spondyloenchondrodysplasia (MIM 607944) 7.7 SEMD, PAPSS2 TYPE; AND BRACHYOLMIA, AUTOSOMAL RECESSIVE TYPE (MIM 271530, 271630) 7.8 Dyggve-Melchior-Clausen Dysplasia (MIM 223800) 7.9 Spondylometaepiphyseal Dysplasia, Short Limb-Abnormal Calcification Type (MIM 271665) 7.10 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY (MIM 608940) 7.11 Dyssegmental Dysplasia (MIM 224400, MIM 244110) 7.12 Schwartz-Jampel Syndrome (MIM 255800) 7.13 Spondyloepiphyseal Dysplasia Tarda, X-Linked (MIM 313400) 7.14 Aggrecan-Associated Skeletal Dysplasias (MIM 608361, 612813) 7.15 Wolcott-Rallison Syndrome (MIM 226980) 7.16 Schimke Immunoosseous Dysplasia (MIM 242900) 7.17 Progressive Pseudorheumatoid Chondrodysplasia (MIM 208230) 7.18 SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE (MIM 184255) 7.19 Sponastrime Dysplasia (MIM 271510) 7.20 CODAS SYNDROME (MIM 600373) 7.21 NANS (N-AcetylNeuraminic acid Synthase) DEFICIENCY (OMIM 610442) 7.22 SPONDYLO-EPI-METAPHYSEAL DYSPLASIA WITH IMMUNE DEFICIENCY AND DEVELOPMENTAL DISABILITY, EXTL3-DEFICIENT TYPE 8. 8.1 Achondrogenesis, Type IB (MIM 600972) 8.2 ATELOSTEOGENESIS TYPE 2 (MIM 256050) 8.3 DIASTROPHIC DYSPLASIA (MIM 222600) 8.4 Multiple Epiphyseal Dysplasia, recessive type (rMED)(MIM 226900) 8.5 DESBUQUOIS DYSPLASIA (MIM 251450) 8.6 Chondrodysplasia with Joint Dislocations, IMPAD1/gPAPP type 8.7 Catel-Manzke Syndrome (MIM 616145) 8.8 Chondrodysplasia with congenital joint dislocations, CHST3-type (MIM 143095) 8.9 TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME (TPBS) (MIM 605282) 8.10 B4GALT7 deficiency (MIM 130070) 8.11 B3GAT3 deficiency (MIM 245600) 8.12 XYLT1 deficiency (MIM 251450) 8.13 Spondyloepimetaphyseal Dysplasia with Joint Laxity BEIGHTON type (MIM 271640) 8.14 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, LEPTODACTYLIC TYPE (MIM 603546) 8.15 Pseudodiastrophic Dysplasia (MIM 264180) 8.16 STEEL SYNDROME (MIM 615155) 9. Filamin-associated Dysplasias/Dysostoses and related disorders 9.1 Otopalatodigital Syndrome Type 1 (MIM 311300) 9.2 Otopalatodigital Syndrome Type II (MIM 304120) 9.3 Melnick-Needles Osteodysplasty(MIM309350) 9.4 Frontometaphyseal Dysplasia (MIM 305620; 617137) 9.5 Boomerang Dysplasia/Atelosteogenesis Type I (MIM 112310, 108720) 9.6 ATELOSTEOGENESIS TYPE III (MIM 108721) 9.7 Larsen Syndrome, Autosomal Dominant (MIM 150250) 9.8 Spondylocarpotarsal Synostosis Syndrome (MIM 272460) 9.9 Frank-ter Haar Syndrome (MIM 249420) 10. PUNCTATE CALCIFICATION GROUP 10.1 Greenberg Dysplasia (MIM 215140) 10.2 CHONDRODYSPLASIA PUNCTATA CONRADI-HÜNERMANN TYPE (MIM 302960) 10.3 CHILD (Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects) Syndrome (MIM 308050) 10.4 Chondrodysplasia Punctata, Rhizomelic Type (MIM 215100, 222765, 600121) 10.5 Chondrodysplasia Punctata, Brachytelephalangic Type (MIM 302950; 602497) 10.6 Chondrodysplasia Punctata, Autosomal Dominant Type (MIM 118650) 10.7 Chondrodysplasia Punctata, Tibia-Metacarpal Type (MIM 118651) 10.8 KEUTEL SYNDROME (MIM 245150) 11. Short-rib (± polydactyly) dysplasias 11.1 Asphyxiating Thoracic Dysplasia (MIM 208500) 11.2 ELLIS VAN CREVELD SYNDROME (MIM 255500) 11.3 Short Rib (±Polydactyly) Syndrome, Saldino-Noonan and Verma-Naumoff types (MIM 613091) 11.4 Short Rib (±Polydactyly) Syndrome, Majewski Type (MIM 263520) 11.5 SHORT RIB (±POLYDACTYLY) SYNDROME, BEEMER-LANGER TYPE (MIM 269860) 11.6 Cranioectodermal Dysplasia (MIM 218330) 11.7 Mainzer-Saldino Syndrome (MIM 266920) 11.8 Axial Spondylometaphyseal Dysplasia (MIM 602271) 12. Rhizo-MESOMELIC DYSPLASIAS 12.1 Omodysplasia, Autosomal recessive (MIM 258315, 268250) 12.2 ROBINOW SYNDROME (MIM 180700, 616331, 616894, 268310) 12.3 DYSCHONDROSTEOSIS (MIM 127300) 12.4 MESOMELIC DYSPLASIA, LANGER TYPE (MIM 249700) 12.5 Mesomelic Dysplasia, Kantaputra Type (MIM 156232) 12.6 Mesomelic Dysplasia, Werner type (MIM 188740; 135750) 12.7 Mesomelic Dysplasia, Reardon-Kozlowski type (MIM 249710) 12.8 Mesomelic Dysplasia, Nievergelt-Savarirayan Type (MIM 163400; 605274) 12.9 Mesomelic Dysplasia with Acral Synostoses (MIM 600383) 13. Acromesomelic AND ACROMELIC Dysplasias/DYSOSTOSeS 13.1 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE (MIM 602875) 13.2 GREBE DYSPLASIA (MIM 200700, 201250, 228900) 13.3 BRACHYDACTYLY A1 (MIM 112500) 13.4 Brachydactyly B (MIM 113000) 13.5 BRACHYDACTYLY C (MIM 113100) 13.6 BRACHYDACTYLY D (MIM 113200) 13.7 BRACHYDACTYLY E (MIM 113300, 613380) 13.8 BRACHYDACTYLY, CHRISTIAN TYPE (MIM 112450) 13.9 TRICHO-RHINO-PHALANGEAL DYSPLASIA, TYPE I (MIM 190350) 13.10 TRICHO-RHINO-PHALANGEAL SYNDROME, TYPE II (MIM 150230) 13.11 Acrocapitofemoral Dysplasia (MIM 607778) 13.12 Albright Hereditary Osteodystrophy(MIM 103580, 600430, 612462, 612463 ) 13.13 ACRODYSOSTOSIS (MIM 101800, 614613) 13.14 Geleophysic Dysplasia (MIM 231050) 13.15 ACROMICRIC DYSPLASIA (MIM 102370) 13.16 MYHRE SYNDROME (MIM 139210) 13.17 SOFT Syndrome (MIM 614813) 14. Osteogenesis Imperfecta and other Disorders with Decreased Bone Density 14.1 Osteogenesis imperfecta 14.2 Osteogenesis Imperfecta, Type I (MIM 116200) 14.3 Osteogenesis Imperfecta, Type IIA (MIM 166210) 14.4 Osteogenesis Imperfecta, Type IIC 14.5 Osteogenesis Imperfecta, Type III/IIB (MIM 259420) 14.6 Osteogenesis Imperfecta, Type IV (MIM 166220) 14.7 Osteogenesis Imperfecta, Type V (MIM 610967) 14.8 Idiopathic Juvenile Osteoporosis (MIM 259750) 14.9 Bruck Syndrome (MIM 259450; 609220; 610968) 14.10 Cole-Carpenter Syndrome (MIM 112240, 616294) 14.11 STüVE-WIEDEMANN syndrome (MIM 601559) 14.12 osteoporosis-pseudoglioma syndrome (MIM 259770) 14.13 Spondyloocular dysplasia (MIM 605822) 14.14 Geroderma Osteodysplasticum (MIM 231070) 14.15 CALVARIAL DOUGHNUT LESIONS-OSTEOPOROSIS SYNDROME (MIM 126550) 14.16 Gnathodiaphyseal Dysplasia (MIM 166260) 15. 15.1 Hypophosphatasia (MIM 146300, 241500, 251510) 15.2 Neonatal Severe Primary Hyperparathyroidism (MIM 239200) 16. Dense Bone Dysplasias with Normal Bone Shape 16.1 Dense Bone Dysplasias with Normal Bone Shape 16.2 Raine Dysplasia (MIM 259775) 16.3 Infantile Osteopetrosis (MIM 259700, 259710, 259720, 611490) 16.4 Osteopetrosis, Intermediate (MIM 259710, 611497) 16.5 Osteopetrosis, Late Onset Forms (MIM 607634, 166660) 16.6 Osteopetrosis with Renal Tubular Acidosis (MIM 259730) 16.7 DYSOSTEOSCLEROSIS (MIM 224300) 16.8 Pyknodysostosis (MIM 265800) 16.9 OsteomesopYknosis (MIM 166450) 16.10 Osteopetrosis, Lymphedema, Ectodermal Dysplasia, Immune Defect (MIM 300301) 16.11 Osteopoikilosis (MIM 166700) 16.12 Melorheostosis (MIM 155950) 16.13 Osteopathia Striata with Cranial Sclerosis (MIM 300373) 17. Dense Bone Dysplasias with Meta-Diaphyseal Modeling Defects 17.1 BLOMSTRAND CHONDRODYSPLASIA (MIM 215045) 17.2 Infantile Cortical Hyperostosis (MIM 114000) 17.3 Dysplastic Cortical Hyperostosis type Kozlowski-Tsuruta 17.4 Osteoectasia with Hyperphosphatasia (MIM 239000) 17.5 Endosteal Hyperostosis, van Buchem type (MIM 239100, 269500) 17.6 Camurati-Engelmann Disease (MIM 131300) 17.7 l Hematodiaphyseal Dysplasia (MIM 231095) 17.8 z-Majewski Hyperostotic Dysplasia (MIM 151050) 17.9 Hypertrophic osteoarthropathy, Autosomal Recessive (MIM 259100) 17.10 Pachydermoperiostosis, Autosomal dominant (MIM 167100) 17.11 Sclerosteo-Cerebellar Syndrome (MIM 213002) 17.12 Craniodiaphyseal Dysplasia (MIM 122860, 218300) 17.13 Craniometaphyseal Dysplasia (MIM 123000; 218400) 17.14 Craniometadiaphyseal Dysplasia wormian bone type (MIM 269300) 17.15 Pyle Disease (MIM 265900) 17.16 Metaphyseal Dysplasia, Braun-Tinschert Type (MIM 605946) 17.17 OCULODENTOOSSEOUS DYSPLASIA (MIM 164200) 17.18 Tricho-dento-osseous Dysplasia (MIM 190320) 17.19 Diaphyseal Medullary Stenosis with Bone Malignancy (MIM 112250) 18. 18.1 Familial Expansile Osteolysis (MIM 174810) 18.2 hyaline fibromatosis (MIM 228600) 18.3 Mandibuloacral Dysplasia (MIM 248370; 608612) 18.4 PROGERIA (MIM 176670) 18.5 Winchester-Torg syndrome (MIM 259600) 18.6 Hajdu-Cheney OSTEOLYSIS (MIM 102500) 18.7 Multicentric Carpal-Tarsal Osteolysis (MIM 166300) 19. DISORDERS CAUSED BY DISORGANIZATION OF SKELETAL CONSTITUENTS 19.1 Fibrous dysplasia (MIM 174800) 19.2 Cherubism (MIM 118400) 19.3 Progressive osseous heteroplasia (MIM 166350) 19.4 Multiple Cartilaginous Exostoses (MIM 133700, 133701, 600209) 19.5 Osteoglophonic Dysplasia (MIM 166250) 19.6 Fibrodysplasia Ossificans Progressiva (MIM 135100) 19.7 Dysplasia Epiphysealis Hemimelica (MIM 127800) 19.8 ENCHONDROMATOSIS (MIM 166000) 19.9 METAPHYSEAL CHONDROMATOSIS WITH 2-HYDROXYGLUTARIC ACIDURIA 19.10 Genochondromatosis (MIM 137360) 19.11 Metachondromatosis (MIM 156250) 20. 20.1 CAMPOMELIC DYSPLASIA (MIM 211990, 114290) 20.2 COUSIN DYSPLASIA (MIM 260660) 20.3 Spondylo-Megaepiphyseal-Metaphyseal Dysplasia (SMMD) (MIM 613330) 20.4 Cleidocranial Dysplasia (MIM 119600) 20.5 Yunis-Varon Syndrome (MIM 216340) 20.6 CDAGS (MIM 603116) 20.7 Nail-Patella Syndrome (MIM 161200) 20.8 Ischio-Pubic-Patellar Dysplasia (MIM 147891) 20.9 Ischiospinal Dysostosis (MIM 608020) 20.10 Cerebro-Costo-Mandibular Syndrome (MIM 117650) 20.11 SAMS SYNDROME (MIM 602471) 21. 21.1 3M Syndrome (MIM 273750, 612921, 614205) 21.2 KENNY-CAFFEY SYNDROME (MIM 127000 (type 2)) 21.3 Osteocraniostenosis (MIM 602361) 21.4 Microcephalic Osteodysplastic Primordial Dwarfism, Types 1 and 3 (MIM 210710, 210730) 21.5 Microcephalic Osteodysplastic Primordial Dwarfism, Type 2 (MIM 210720) 21.6 IMAGE (Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, and Genital Anomalies) Syndrome (MIM 614732) 22. OVERGROWTH / ACCELERATED SKELETAL MATURATION SYNDROMES (SELECTED) 22.1 Marshall-Smith syndrome (MIM 602535) 22.2 Marshall-Smith syndrome (MIM 602535) 22.3 WEAVER SYNDROME (MIM 277590) 22.4 CNP-overexpression Overgrowth Syndrome (MIM 615923) 23. CRANIOSYNOSTOSIS SYNDROMES 23.1 APERT SYNDROME (MIM 101200) 23.2 Pfeiffer Syndrome (MIM 101600, 136350) 23.3 Antley-Bixler Syndrome (MIM 201750) 23.4 Saethre-Chotzen Syndrome (MIM 101400) 23.5 Baller-Gerold Syndrome (MIM 218600, 266280) 23.6 CARPENTER SYNDROME (MIM 201000, 614970) 23.7 MUENKE SYNDROME (MIM 602849) 23.8 BENT BONE DYSPLASIA-FGFR2 TYPE (MIM 614592) 24. Spondylocostal dysostoses (SCD) 25. 25.1 AL-AWADI RAAS-ROTHSCHILD SYNDROME (MIM 276820, 228930) 25.2 Roberts/SC Phocomelia Syndrome (MIM 268300, 269000) 25.3 Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip/Palate Syndrome (MIM 129900; 604292) 25.4 SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY (SHFLD) (MIM 119100, 610685, 612576) 25.5 FemoraL-Facial Syndrome (FFS) (MIM 134780) 25.6 Femur-Fibula-Ulna Syndrome (MIM 228200) 25.7 POLAND SYNDROME (MIM 173800) 25.8 NAGER SYNDROME (MIM 154400, 201170 ) 26. DISORDERS WITH DEFECTIVE JOINT FORMATION 26.1 Multiple Synostoses Syndrome (MIM 186500; 186570; 610017; 612961) 26.2 Liebenberg Syndrome (MIM 186550) Index

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThe process of genetic counselling involves many key components, such as taking a family genetic history, making a diagnosis, and providing communication and support to the family. Among these core processes is the mathematical calculation of the actual risk of a possible genetic disorder. For most physicians and counsellors, the mathematics and statistics involved can be a major challenge which is not always helped by complex computer programs or lengthy papers full of elaborate formulae. In this clear, reader-friendly guide, Ian Young addresses this problem and demonstrates how risk can be estimated for inherited disorders using a basic knowledge of the laws of probability and their application to clinical problems. The text employs a wealth of clearly explained examples and key points in order to guide the reader to an accurate assessment of the risk of genetic disease. It primarily will appeal to genetic counsellors, geneticists, and all those involved in providing medical genetic services.In this new edition, Dr. Young has pruned redundancies and extensively updated the concepts in each of the 10 chapters, and he has included more working examples, a popular feature of the book.Table of ContentsULTRASOUND AND PRENATAL DIAGNOSIS; OVERLAPPING NORMAL DISTRIBUTIONS; LENGTH OF PROMETAPHASE CHROMOSOME SEGMENTS

Read more less

Book SynopsisGenetic Counseling Research: A Practical Guide is the first text devoted to research methodology in genetic counseling. This text offers step-by-step guidance for conducting research, from the development of a question to the publication of findings. Genetic counseling examples, user-friendly worksheets, and practical tips guide readers through the research and publication processes.With a highly accessible, pedagogical approach, this book will help promote quality research by genetic counselors and research supervisors--and in turn, increase the knowledge base for genetic counseling practice, other aspects of genetic counseling service delivery, and professional education. It will be an invaluable resource to the next generation of genetic counseling and its surrounding disciplines.Trade ReviewThe authors have done an excellent job with this manual of scientific methodology oriented to genetic counselors... The value of this book lies in the simplicity of its presentation and its usefulness to beginning genetic counselors who plan to embark on research and scientific writing. * Doody's Notes *Table of ContentsPreface ; Chapter 1: Developing Research Questions ; Chapter 2: Finding Sources ; Chapter 3: Writing a Review of Literature ; Chapter 4: Ethics in Research ; Chapter 5: Choosing a Paradigm ; Chapter 6: Designing a Quantitative Study ; Chapter 7: Quantitative Data Analysis: I've got data, how do I get answers? ; Chapter 8: Conducting Qualitative Genetic Counseling Research ; Chapter 9: Preparing a Manuscript for Publication ; Chapter 10: Guidelines for Directing Research ; References ; Appendix: Additional Resources for Researchers and Research Supervisors

Read more less

Book SynopsisNystagmus in Infancy and Childhood is a highly-illustrative and thoughtfully written text that provides clinicians and scientists with detailed yet concise information regarding our current understanding, evaluation, and treatments of nystagmus in infancy and childhood. Throughout the text are clinical pearls and narrative observations intended to help the reader appreciate the enormous strides forward in the past 50 years of nystagmus research. Timely and comprehensive, this book is an everything you need to know resource, and will provide the reader with:- detailed methodologies of investigation, including analysis software, models of the ocular motor system, and current hypotheses regarding ocular motor oscillations- complementary appendices that can be used for special purposes, i.e., as clinical examination sheets, patient information sheets, and algorithm for computer analysis of nystagmus waveforms- new therapeutic approaches, using relevant eye-movement data and mechanisms- a rTrade Review"This book is unique in that it describes, illustrates, and shares current understanding, evaluation and treatment of nystagmus in infancy and childhood. The duo of authors named below have broadened the frontiers of knowledge on this disorder, as you will discover from the research-based information provided in this book, with discussions and reference sources; and graphics, including charts, figures, formulas, images, and tables." --Biz India "...Enterprising and bold, and is an invaluable, eminently readable book for clinicians, vision scientists, and trainees." --PerceptionTable of ContentsChapter 1. Relevant Anatomy and Physiology ; 1.1 INFRANUCLEAR OCULAR MOTOR ANATOMY ; 1.1.1 Extraocular Muscles ; 1.1.2 Extraocular Muscle Pulleys ; 1.1.3 Orbital Tissues ; 1.2 SUPRANUCLEAR OCULAR MOTOR ANATOMY ; 1.2.1 Frontal Eye Fields ; 1.2.2 Superior Colliculus ; 1.2.3 Brainstem Nuclei ; 1.2.4 Vestibular Nuclei ; 1.2.5 Cerebellum ; 1.3 AFFERENT SYSTEM ; 1.3.1 Retina/Optic Nerve ; 1.3.2 Optic Nerve ; 1.3.3 Lateral Geniculate ; 1.3.4 Geniculostriate ; 1.3.5 Association Cortex ; 1.3.6 Ocular Motor Proprioception ; 1.4 EFFERENT SYSTEM ; 1.4.1 Smooth Pursuit System ; 1.4.2 Saccadic System ; 1.4.3 Vergence System ; 1.4.4 Vestibuloocular System ; Chapter 2. Infantile Nystagmus SyInfantile Nystagmus Syndromendrome ; 2.1 CHARACTERISTICS OF INS ; 2.1.1 History and Background ; 2.1.1.1 Ancient Descriptions and Theories ; 2.1.1.2 Connection to Fixation Attempt ; 2.1.1.3 Modern Physiological Investigation ; 2.1.2 Waveforms, Models, and Mechanisms ; 2.1.2.1 Waveform Types ; 2.1.2.2 Braking and Foveating Saccades ; 2.1.2.3 The Foveation Period ; 2.1.2.4 Foveation Accuracy ; 2.1.2.5 Target Acquisition Time ; 2.1.2.6 Smooth Pursuit ; 2.1.3 The Static Neutral Zone/Region ; 2.1.3.1 Latent Component ; 2.1.4 The Dynamic Neutral Zone/Region ; 2.1.4.1 Asymmetric, (a)Periodic Alternation ; 2.1.4.2 Optokinetic, Pursuit and Vestibuloocular Responses ; 2.1.5 The Null Angle/Zone/Region ; 2.1.6 The Convergence Null ; 2.1.7 The Saccadic Response ; 2.1.8 Static and Dynamic Head Posturing ; 2.1.9 Foveation and Visual Acuity (High Spatial Frequency Vision) ; 2.1.9.1. The eXpanded Nystagmus Acuity Function (NAFX) ; 2.1.9.1.1 NAFX vs. Gaze Angle ; 2.1.9.1.2 LFD and TID ; 2.1.10 Oscillopsia Suppression ; 2.1.10.1 Foveation Dynamics ; 2.1.10.2 Temporal Sampling ; 2.1.10.3 Efference Copy ; 2.1.11 Afferent Stimulation ; 2.1.11.1 Cutaneous Trigeminal Stimulation ; 2.1.11.2 Deep Muscle Stimulation ; 2.1.11.3 Contact Lenses ; 2.1.11.4 Biofeedback ; 2.1.12 Canine Nystagmus (Achiasmatic Belgian Sheepdog) ; 2.1.12.1 See-Saw ; 2.1.12.2 Pendular ; 2.1.12.3 Tenotomy & Reattachment Procedure ; 2.1.13 Canine Model of INS with RPE65 Retinal Degeneration (Briard) ; 2.2 ETIOLOGY OF INS ; 2.2.1 Familial (Gene Defect) ; 2.2.2 Developmental Disturbance Of Ocular Motor System with Associated Sensory System Deficit. ; 2.2.2.1 Albinism ; 2.2.2.2 Achiasma ; 2.2.2.3 Infantile Strabismus ; 2.2.2.4 Non-vectorial Visual Sensory Deficits ; 2.2.3 The Direct Cause(s) of INS with or without Sensory/Genetic Deficits ; 2.2.3.1 Loss of Smooth-Pursuit Damping ; 2.2.3.2 Tonic Vestibular-Optokinetic Imbalance ; 2.3 VISUAL FUNCTION DEFICITS AND MEASUREMENTS OF INS ; 2.3.1 Static Deficits ; 2.3.1.1 The eXpanded Nystagmus Acuity Function and Longest Foveation ; Domain Measures ; 2.3.2 Dynamic Deficits ; 2.3.2.1 Target Acquisition Time (Stationary Targets) ; 2.3.2.2 Target Acquisition Time (Moving Targets) ; 2.3.3 Clinical ; 2.3.3.1 Visual Acuity at Different Gaze Angles ; 2.4 TREATMENTS OF INS ; 2.4.1 Goals ; 2.4.2 Non-Surgical ; 2.4.2.1 Prisms ; 2.4.2.2 Contact Lenses ; 2.4.2.3 Drugs ; 2.4.2.4 Biofeedback ; 2.4.2.5 Gene-Transfer Therapy ; 2.4.3 Surgical ; 2.4.3.1 Four-Muscle Resection & Recession Procedure (Operation 1) ; (aka Kestenbaum, Anderson-Kestenbaum, or Anderson+Goto) ; 2.4.3.2 Two-Muscle Recession Procedure (Operation 1A) (aka Anderson) ; 2.4.3.3 Bilateral Medial Rectus Recession Procedure (Operation 8) ; 2.4.3.4 Tenotomy & Reattachment Procedure (Operation 6) ; Chapter 3. Fusion Maldevelopment Nystagmus Syndrome ; 3.1 CHARACTERISTICS OF FMNS ; 3.1.1 Waveforms, Models, and Mechanisms ; 3.1.1.1 Types (FMNS plus Nucleus of the Optic Tract) ; 3.1.1.2 The Fixating Eye ; 3.1.1.3 Target Foveation and Dual-Mode Fast Phases ; 3.1.1.4 Foveation Accuracy ; 3.1.2 Variation with Gaze Angle ; 3.1.3 Head Position ; 3.1.4 Foveation, NAFX, and Acuity ; 3.1.5 Efference Copy, Foveation, and Oscillopsia Suppression ; 3.2 TREATMENTS OF FMNS ; 3.2.1. Fixation Preference ; 3.2.2. Alexander's Law ; 3.2.3. Eye Muscle Surgery ; Chapter 4. Other Types of Nystagmus of Infancy ; 4.1 NYSTAGMUS BLOCKAGE SYNDROME ; 4.1.1 Characteristics of NBS ; 4.1.1.1 Multiple Types of Nystagmus ; 4.1.1.2 Waveforms and Mechanisms ; 4.1.1.2.1 Target Foveation ; 4.1.1.2.2 Foveation Accuracy ; 4.1.1.3 Purposive Esotropia ; 4.1.1.4 Head Position ; 4.1.1.5 Blockage Syndrome Types I and II ; 4.1.1.6 Foveation, NAFX, and Acuity ; 4.1.1.7 Efference Copy, Foveation, and Oscillopsia Suppression ; 4.1.2 Treatments of NBS ; 4.1.2.1. Fixation Preference ; 4.1.2.2. Alexander's Law ; 4.1.2.3. Surgical ; 4.1.2.3.1. Fixating Eye ; 4.2 SPASMUS NUTANS SYNDROME ; 4.2.1 Characteristics of SNS ; 4.2.1.1 Waveforms and Mechanisms ; 4.2.1.2 Variable Interocular Phase ; 4.2.1.3 Head Nodding ; 4.2.2 Treatment of SNS ; Chapter 5. Differential Diagnosis of Nystagmus In Infancy and Childhood ; 5.1 NYSTAGMUS WITHOUT ASSOCIATED NEUROLOGICAL DISEASE-<"BENIGN>" ; 5.1.1. Infantile Nystagmus Syndrome ; 5.1.1.1 Association with Strabismus ; 5.1.1.2 Clinical Signs and Symptoms ; 5.1.1.3 Differential Diagnosis ; 5.1.1.4 Reverse-Cover and Gaze-Angle Cover Tests ; 5.1.2 Fusion Maldevelopment Nystagmus Syndrome ; 5.1.2.1 Association with Strabismus ; 5.1.2.2 Clinical Signs and Symptoms ; 5.1.2.3 Differential Diagnosis ; 5.1.2.4 Alternate-Cover and Gaze-Angle Cover Tests ; 5.1.3 Nystagmus Blockage Syndrome ; 5.1.3.1 Association with Strabismus ; 5.1.3.2 Clinical Signs and Symptoms ; 5.1.3.3 Differential Diagnosis ; 5.1.4 Spasmus Nutans Syndrome ; 5.1.4.1 Association with Strabismus ; 5.1.4.2 Clinical Signs and Symptoms ; 5.1.4.3 Differential Diagnosis ; 5.1.5 Nystagmus and Strabismus ; 5.2 NYSTAGMUS WITH ASSOCIATED NEUROLOGICAL DISEASE-<"SYMPTOMATIC>" ; 5.2.1 Vestibular Nystagmus ; 5.2.1.1 Peripheral Vestibular Imbalance ; 5.2.1.2 Central Vestibular Imbalance ; 5.2.1.3 Central Vestibular Instability (Periodic Alternating) ; 5.2.2 Gaze-holding Deficiency Nystagmus ; 5.2.2.1 Eccentric Gaze, Gaze-evoked, Rebound ; 5.2.2.2 Gaze Instability (<"Run-away>") ; 5.2.3 <"Vision-Loss>" Nystagmus ; 5.2.3.1 Pre-chiasmal, Optic Chiasm, Post-chiasmal Vision Loss ; 5.2.4 Other Pendular Nystagmus Associated with Diseases of Central Myelin ; 5.2.4.1 Oculopalatal Tremor or <"Myoclonus>" ; 5.2.4.2 Pendular Vergence Nystagmus Associated with Whipple's Disease ; 5.2.5 Convergence/Convergence Evoked Nystagmus ; 5.2.6 Upbeat Nystagmus ; 5.2.7 Downbeat Nystagmus ; 5.2.8 Torsional Nystagmus ; 5.2.9 <"See-Saw>" Nystagmus ; 5.2.10 Lid Nystagmus ; 5.3 SACCADIC INTRUSIONS/OSCILLATIONS ; 5.3.1 Square Wave Jerks And Oscillations ; 5.3.2 Square-Wave Pulses ; 5.3.3 Staircase Saccadic Intrusions ; 5.3.4 Macrosaccadic Oscillations ; 5.3.5 Saccadic Pulses (Single And Double) ; 5.3.6 Convergence Retraction <"Nystagmus>" ; 5.3.7 Dissociated Ocular Oscillations ; 5.3.8 Dysmetric Saccades ; 5.3.9 Ocular Flutter ; 5.3.10 Flutter Dysmetria ; 5.3.11 Opsoclonus ; 5.3.11.1 Opsoclonus-Myoclonus ; 5.3.12 Superior Oblique Myokymia ; 5.3.13 Ocular bobbing ; 5.3.13.1 Typical ; 5.3.13.2 Monocular ; 5.3.13.3 Atypical ; 5.3.14 Psychogenic (Voluntary) Flutter ; Chapter 6. Afferent Visual System - Clinical Examination Procedures ; 6.1 SUBJECTIVE TESTING ; 6.1.1 Teller Acuity Card Procedure ; 6.1.2 Visual Acuity Testing (High Spatial Frequency Vision) ; 6.1.3 Stereo Testing ; 6.1.4 Color-Vision Testing ; 6.1.5 Contrast-Sensitivity Testing ; 6.1.6 Gaze- and Time-Dependent Acuity Testing ; 6.1.7 Visual Field Testing ; 6.2 OBJECTIVE TESTING ; 6.2.1 Visual Evoked Potentials ; 6.2.2 Electroretinography ; 6.2.3 Optical Coherence Tomography ; 6.2.4 Fundus Photography ; Chapter 7. Treatment ; 7.1 MEDICAL ; 7.1.1 Optical ; 7.1.1.1 Version Prisms ; 7.1.1.2 Vergence Prisms ; 7.1.1.3 Contact Lenses ; 7.1.1.4 Correction of Ammetropia/Anisometropia ; 7.1.1.5 Intraocular Lenses ; 7.1.1.6 Refractive Surgery ; 7.1.2 Pharmacological ; 7.1.2.1 Sedatives/Hypnotics ; 7.1.2.2 Neuroleptics ; 7.1.2.3 Psychoactive Medications ; 7.1.2.4 Antiseizure Medications ; 7.1.2.5 Botulinum ; 7.1.2.6 Anticholinesterases ; 7.2 EYE-MUSCLE SURGERY ; 7.2.1 General Principles ; 7.2.2 Classification ; 7.2.3 Preoperative Evaluation ; 7.2.3.1 Visual Acuity ; 7.2.3.2 Ocular Motor and Standard Clinical Evaluations ; 7.2.3.3 Strabismus ; 7.2.3.4 Eye-Movement Recordings ; 7.2.3.5 Head-Posture Measurements (<"Null Zones>") ; 7.2.3.6 Laboratory and Special Tests ; 7.2.4 Results ; 7.2.4.1 Visual Acuity ; 7.2.4.2 Strabismus ; 7.2.4.3 Eye-Movement Recordings ; 7.2.4.4 Head-Posture Measurements ; 7.2.5 Complications ; 7.3 OTHER ; 7.3.1 Biofeedback ; 7.3.2 Acupuncture ; 7.3.3 Cutaneous Stimulation ; 7.3.4 Gene Transfer Therapy ; 7.3.5 Mind-Body Stress Reduction-Mindful Medication Techniques ; 7.3.6 Occupational and Vision Therapy ; 7.3.7 Educational Assistance ; 7.4 ASSESSING THERAPEUTIC OUTCOMES (POST-THERAPY) ; 7.4.1 Direct Outcome Measures (NAFX, LFD, and Lt) ; 7.4.1.1 Post-Tenotomy & Reattachment ; 7.4.1.2 Post-Convergence/Bimedial Rectus Recession ; 7.4.1.3 Post-Four-Muscle Recession & Resection ; or Two-Muscle Recession + Tenotomy & Reattachment ; 7.4.1.4 Soft Contact Lenses ; 7.4.1.5 Systemic Acetazolamide and Topical Brinzolamide ; 7.4.2 Indirect/Clinical Outcome Measures ; 7.4.2.1 Visual Acuity at Different Gaze Angles ; 7.5 ESTIMATING THERAPEUTIC OUTCOMES (POST-THERAPY) ; 7.5.1 Direct Outcome Measures (NAFX, LFD, and Lt) ; 7.5.1.1 Tenotomy & Reattachment (INS without Afferent Visual Deficits) ; 7.5.1.2 Tenotomy & Reattachment (INS with Afferent Visual Deficits) ; 7.5.1.3 Prisms/Bimedial Rectus Recession ; 7.5.1.4 Soft Contact Lenses ; 7.5.2 Indirect/Clinical Outcome Measures ; 7.5.2.1 Visual Acuity at Different Gaze Angles ; Chapter 8. Summary and Conclusions ; Epilogue ; Appendices ; Appendix A. Eye-Movement Recording Systems and Criteria ; A.1 RECORDING METHODS ; A.1.1 Contact Electrooculography ; A.1.2 Infrared Reflection ; A.1.3 Scleral Search Coil ; A.1.4 High-Speed Video Oculography ; A.2 RESEARCH CRITERIA ; A.2.1 NAFX ; A.2.1.1 Methodology ; A.2.1.2 Estimating Visual Function Improvements ; A.3 CLINICAL CRITERIA ; A.3.1 Waveform Types ; A.3.2 Null and Neutral Zones ; A.3.3 PAN and APAN ; A.3.4 Symmetry, Conjugacy, Vergence, and Monocular Evaluation ; A.4 CALIBRATION TECHNIQUES ; A.4.1 Adults and Children ; A.4.1.1 Infantile Nystagmus ; A.4.1.2 Fusion Maldevelopment Nystagmus ; A.4.2 Infants ; Appendix B. Clinical Examination ; B.1 GENERAL CLINICAL EXAMINATION FORM ; B.2 NYSTAGMUS EXAMINATION FORM ; B.3 STRABISMUS EXAMINATION FORM ; B.4 CLINICAL PEARLS ; B.5 OPHTHALMOLOGICAL MYTHS AND FACTS ; Appendix C. Illustrative Cases and Treatment ; C.1 INFANTILE NYSTAGMUS SYNDROME ; C.1.1 Gaze-Angle Null Only ; C.1.1.1 Version Prisms ; C.1.1.2 Soft Contact Lenses ; C.1.1.3 Four-Muscle Resection, Recession, and Tenotomy & Reattachment ; C.1.1.3.1. Fine Tuning with Prisms ; C.1.1.3.2. Soft Contact Lenses ; C.1.2 Convergence Null Only ; C.1.2.1 Vergence Prisms with Negative Spheres ; C.1.2.2 Soft Contact Lenses ; C.1.2.3 Bimedial Recession ; C.1.3 Both Gaze-Angle and Convergence Nulls ; C.1.3.1 Convergence > Gaze-Angle ; C.1.3.1.1 Composite Prisms and Negative Spheres ; C.1.3.1.2 Base-out Prisms and Negative Spheres ; C.1.3.1.3 Soft Contact Lenses ; C.1.3.1.4 Bimedial Recession ; C.1.3.2 Gaze-Angle > Convergence ; C.1.3.2.1 Version Prisms ; C.1.3.2.2 Soft Contact Lenses ; C.1.3.2.3 Four-Muscle Resection, Recession and ; Tenotomy & Reattachment ; C.1.4 No Nulls ; C.1.4.1 Soft Contact Lenses ; C.1.4.2 Four-Muscle Tenotomy & Reattachment ; C.1.4.2.1 Tenotomy & Reattachment with Augmented ; Tendon Suture ; C.1.4.2.2 Augmented Tendon Suture Procedure sans ; Tenotomy & Reattachment ; C.1.4.3 Faden ; C.2 INFANTILE NYSTAGMUS PLUS STRABISMUS ; C.2.1 Gaze-Angle Null Only ; C.2.1.1 Four-Muscle Resection, Recession and Tenotomy & Reattachment ; C.2.2 Vertical and Torsional Nulls ; C.2.3 No Nulls ; C.2.3.1 Four-Muscle Tenotomy & Reattachment and Strabismus ; C.3 FUSION MALDEVELOPMENT NYSTAGMUS SYNDROME ; C.3.1 Uniocular Fixation ; C.3.2 Alternating Fixation ; C.3.3 Alexander's Law Threshold ; C.4 NYSTAGMUS BLOCKAGE SYNDROME ; C.4.1 Bimedial Recession (plus Tenotomy & Reattachment) ; C.4.2 Recession and Resection plus Tenotomy & Reattachment ; C.4.3 Four-Muscle Tenotomy & Reattachment ; Appendix D. Diagnosis and Treatment Flow Charts ; D.1 WAVEFORM-BASED DIAGNOSES ; D.2 THERAPEUTICALLY EXPLOITABLE WAVEFORM CHARACTERISTICS ; D.3 CLINICALLY BASED DIAGNOSES AND LIMITATIONS ; D.4 THERAPEUTICALLY EXPLOITABLE CLINICAL CHARACTERISTICS ; D.5 ANALYSIS GRAPHS ; Appendix E. Included Compact Disk and On-Line Access Videos ; E.1 <"EYEBALLS 3D>" EYE-MOTION AND WAVEFORM VIDEOS ; MV1 INS (PPfs) 1 cycle 1/20-speed illustrating foveation period ; MV2 INS (Jef) 4 cycles 1/3-speed with phase plane ; MV3 INS (PPfs) 3 cycles 1/2-speed illustrating well-developed foveation ; MV4 INS (PPfs) 3 cycles 1/5-speed with phase plane ; MV5 INS (PPfs) 1/2-speed 3-dimensional motion with subclinical SSN ; MV6 INS 1/5-speed Subclinical SSN motion amplified ; MV7 INS PPfs 1/2-speed from OMS model and patient ; MV8 INS (Pfs) step responses OMS model ; MV9 INS (PPfs) 1/2-speed pulse responses OMS model ; MV10 INS (PPfs) 1/2-speed OMS model ramp and step-ramp responses ; MV11 FMNS gaze-angle effect OMS model ; MV12 FMNS 1/2-speed alternate cover test OMS model ; MV13 FMNS adducting eye fixation OMS model ; MV14 INS damping with rapid convergence ; MV15 INS 1/2-speed pre-T&R ; MV16 INS 1/2-speed post-T&R ; MV17 INS 1/2-speed RPE65-deficient canine pre-gene therapy MV18 INS 1/2-speed RPE65-deficient canine pre-gene therapy scan path ; MV19 INS 1/2-speed RPE65-deficient canine post-gene therapy MV20 INS 1/2-speed RPE65-deficient canine post-gene therapy scan path ; MV21 Oscillopsia simulation ; MV22 Uniocular APN pre- and post-therapy ; MV23 INS (alternating J) OMS model ; E.1.1 PowerPoint Files ; E.1.1 E1_INS Dynamic VA ; E.1.2 E1_INS Latency Poster ; E.1.3 E1_ INS Latency ; E.1.4 E1_ INS Model Poster ; E.2 CANINE VIDEOS (PLUS OTHERS) ; CV1 Normal Brittany ; CV2 Achiasmatic Belgian Sheepdog: pre-T&R ; CV3 Achiasmatic Belgian Sheepdog: post-T&R ; CV4 RPE65-deficient canine: pre-gene therapy behavior ; CV5 RPE65-deficient canine: post-gene therapy behavior ; CV6 RPE65-deficient canine: pre-gene therapy eye movements ; CV7 RPE65-deficient canine: post-gene therapy eye movements ; CV8 Cat with INS ; CV9 Goat with SSN ; E.3 PATIENT VIDEOS ; PV1 Saccadic Initiation Failure ; PV2 Brainstem Tumor: Tonic Gaze Deviation ; PV3 Acquired Downbeat Nystagmus ; PV4 Acquired Gaze-Evoked (Gaze-Holding Failure) Nystagmus ; PV5 Acquired Unidirectional Gaze-Evoked (Gaze-Holding Failure) Nystagmus ; PV6 Ocular Motor Neuromyotonia of Cranial Nerve III ; PV7 Ocular Motor Neuromyotonia of Cranial Nerve VI ; PV8 Infant with Opsoclonus (Ocular Flutter - <"Saccadomania>") ; PV9 Acquired Saccadic Oscillations-1 ; PV10 Acquired Saccadic Oscillations-2 ; PV11Acquired Saccadic Oscillations-3 ; PV12 Acquired Nystagmus + Saccadic Oscillations ; PV13 Acquired Upbeat Nystagmus with Wiernecke's Encephalopathy ; PV14 Acquired Vertical Pendular Nystagmus ; PV15 Fusion Maldevelopment Nystagmus-1 ; PV16 Fusion Maldevelopment Nystagmus-2 ; PV17 Down Syndrome and Infantile Nystagmus ; PV18 Achiasma + See-Saw Nystagmus + Infantile Nystagmus ; PV19 Octogenarian with Infantile Nystagmus ; PV20 Infantile Nystagmus: Aperiodically Changing Intensity (Not Direction) ; PV21 Infantile Nystagmus: Aperiodically Changing Direction (Not Intensity) ; PV22 Infantile Nystagmus: Unequal-1 ; PV23 Infantile Nystagmus: Unequal-2 ; PV24 Infantile Nystagmus: Unequal-3 ; PV25 Infantile Nystagmus: Jerk with Extended Foveation ; PV26 Infantile + NOT Nystagmus: Dual Jerk ; PV27 Infantile Nystagmus: Pre- and Post-Operative ; PV28 Optic Nerve Dysplasia and Infantile Nystagmus: Multiplanar ; PV29 Infantile Nystagmus: Jerk with Extended Foveation ; PV30 Infantile Nystagmus: Unequal with a <"latent component>" ; PV31 Albinism and Infantile Nystagmus ; PV32 Optic Nerve Dysplasia and Infantile Nystagmus: Multiplanar ; PV33 Albinism, Up-gaze Null, and Infantile Nystagmus: Equal ; PV34 Retinal Dystrophy and Infantile Nystagmus: Multiplanar ; PV35 Albinism and Infantile Nystagmus: Pre- and Post-Operative Horizontal Null ; PV36 Albinism and Infantile Nystagmus: Multiplanar ; PV37 Infantile Nystagmus: Periodic Alternating ; PV38 Infantile Nystagmus: Asymmetric Aperiodic Alternating ; PV39 Albinism and Infantile Nystagmus: Pre- and Post-Operative Vertical Null ; PV40 Albinism, Up-gaze Null, and Infantile Nystagmus ; PV41 Albinism and Infantile Nystagmus ; PV42 <"Vertical>" Infantile Nystagmus-1 ; PV43 Retinal Dystrophy and <"Vertical>" Infantile Nystagmus-2 ; PV44 Spasmus Nutans Nystagmus-1 ; PV45 Spasmus Nutans Nystagmus-2 ; PV46 Voluntary Ocular Flutter ; Appendix F. Included Compact Disk and On-Line Access ; F.1 OMLAB REPORTS ; F.1.1 #011105 Recording and Calibrating the Eye Movements of Nystagmus Subjects ; F.1.2 #111005 Using the NAFX for Eye-Movement Fixation Data Analysis and Display ; F.1.3 #111905 Nystagmus Therapies: Types, Sites, and Measures ; F.1.4 #090506 Original Ocular Motor Analysis of the First Human with Achiasma: ; Documentation of Work Done in 1994 ; F.1.5 #123007 The Benefits of Extraocular Muscle Surgery in INS ; F.1.6 #030509 How Someone <"Sees>" the World and How to Clinically Assess ; Therapeutic Improvements in Visual Function ; F.2 PATIENT HANDOUTS ; F.2.1 INS Information ; F.2.2 INS Treatments ; F.2.3 Tenotomy and Reattachment ; F.2.4 INS and Acuity ; F.2.5 INS Miscellaneous ; F.3 PHYSICIAN/RESEARCH SCIENTIST WORKSHEETS ; F.3.1 Recession and Resection Surgical Calculation ; F.3.2 Estimating Improvement in Peak NAFX ; F.3.3 Estimating Improvement in LFD ; F.3.4 NAFX vs. Visual Acuity (Motor and Sensory Components) ; F.4 CLINICAL EXAMINATION FORMS ; F.4.1 General Clinical Examination Form ; F.4.2 Nystagmus Examination Form ; F.4.3 Strabismus Examination Form ; F.5 ANALYSIS SOFTWARE ; F.5.1 OMtools ; F.5.2 OMS Model GUI User Guide

Read more less

Trade ReviewGenomics and Clinical Medicine is the first textbook to comprehensively examine Medicine, especially pathophysiology and pathogenesis, through the lens of genomics. * JAMA *...written by an equally outstanding roaster of authors, deal with all aspects of Genomic Medicine. The book combines general principles, and specific aspects of clinical practice, all in the light of genome analysis and the current laboratory methodologies." * Stylianos E. Antonarakis, Professor and Chairman of Genetic Medicine, University of Geneva, President of Human Genome Organization, Geneva, Switzerland *...most physicians have had little or no training in genetics or genomics, and will be hard pressed to quickly acquire the scientific principles, the medical knowledge, and the psychosocial skills that will be necessary for the successful introduction of genomic medicine. Busy practitioners will desperately need an authoritative source of information that includes both principles and specific applications. The introduction of this textbook, with its distinguished and authoritative list of contributors, thus arrives in the nick of time. Welcome to the genome era. * Francis S. Collins, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA *...the book is a nice overview of developments in different fields of genomic medicine, written by a number of experts who give a thorough description of their argument. * European Journal of Human Genetics *Genomics and Clinical Medicine could be used during the first or second year of medical school to provide an underpinning of genomics as a unifying theme to the diverse array of topics that are typically taught at this time. * New England Journal of Medicine *This is a pioneering work of two doctors who as editors, have undertaken a monumental project, compiling a lot of relatively new knowledge put on paper by a total 50 pioneers in genomic medicine. All the authors and Drs. Kumar and Eng are to be congratulated for this unique, massive contribution to better understanding of disease so that eventually, millions of people can benefit from their work, to lead healthier lives. * Biz India Book Review *Table of ContentsPart I: Principles of Genomic Medicine ; 1. Genes, genetics and human genomics- Dhavendra Kumar ; 2. The human genome- structure and organization- Andrew P. Read ; 3. Human Proteomics- Brian Morrissey, Lisa Staunton, Stephen R Pennington ; 4. Epigenetics, Epigenomics and Human Disease- Aravind Ramesh, Cihangir Yandim, Theona Natisvili, Marta Mauri, Piu Pik Law, Jackson P.K. Chan, Santiago Uribe Lewis, Richard Festenstein ; 5. Genes, genome and developmental malformations- Dhavendra Kumar ; 6. Bioinformatics, Systems Biology and Systems Medicine- Binay Panda and Neeraja M Krishnan ; 7. Pharmacogenomics - Critical Component of Genomic Medicine- Wolfgang Sadee ; 8. New Drug Development, Drug Response, and Precision Medicines- Michelle Penny and Duncan McHale ; 9. Mitochondrial genetics and genomics in clinical medicine- Agnes Rotig and Dhavendra Kumar ; 10. Genomics Technology in Clinical Diagnostics- Kevin White ; 11. Microbial Genomics: targeted antimicrobial therapy and genome vaccines- Immaculada Margarit & Rino Rappuoli ; 12. Nutritional genomics- Zhenglong Gu, Kaixiong Ye and Patrick J. Stover ; 13. Genomics in Public and Population Health- Anastasia L. Wise and Teri A. Manolio ; 14. Genetic testing and genomic screening- Angus J. Clarke ; 15. Biobanking for genomics-based translational medicine- Steven J. Madore ; 16. Genetics and Genomics Education: The Path from Helix to Health- Reed E. Pyeritz ; 17. Ethical, Legal and Social Issues in Clinical Genomics- Caroline F. Wright, Anna Middleton & Michael Parker ; 18. The regulation of human genomics research- Jane Kaye ; Part II: Genomics in Clinical Practice ; 19. Genetic and genomic approaches to clinical medicine - Dhavendra Kumar ; 20. Genetic and genomic taxonomy of human disease - Dhavendra Kumar ; 21. Genomics of complex cardiovascular disease- Foram Ashar and Dan E. Arking ; 22. Genomics of type 2 diabetes mellitus and obesity-V. Radha and V. Mohan ; 23. Genetics and genomics of osteoporosis and related disorders- Yoshiji Yamada ; 24. Genetics and Genomics of chronic kidney disease- Albert C.M.Ong and Alexander P. Maxwell ; 25. Genetics and genomics in clinical hematology I- Hemostasis and Thrombosis- John Mcvey ; 26. Genetics and genomics in clinical hematology II- Inherited disorders of haemoglobin- David J. Weatherall ; 27. Genetics and genomics in clinical hematology III- Acute leukemias- Kenneth Mills ; 28. Genetics and Genomics of Chronic Inflammatory disorders I: Inflammatory Bowel Disease- Saad Pathan ; 29. Genetics and Genomics of Chronic Inflammatory disorders II: Rheumatoid Arthritis and Related Arthropathies- Kate McAllister and Stephen Eyre ; 30. Genetics and Genomics of Chronic Inflammatory disorders III: Bronchial asthma- William Cookson ; 31. Genetics and genomics of neuro-psychiatric diseases I: Seizure disorders - William Owen Pickrell ; 32. Genetics and genomics of neuro-psychiatric diseases II: Multiple Sclerosis- Katharine Harding and Neil Robertson ; 33. Genetics and genomics of neuro-psychiatric diseases III: The Common Dementias- Amy Gerrish, Rebecca Sims and Julie Williams ; 34. Genetics and genomics of neuro-psychiatric diseases IV: Schizophrenia and Bipolar Disorder - Jinbo Fan ; 35. Genetics and genomics of neuro-psychiatric diseases V: Learning and behavioural disorders- F Lucy Raymond ; 36. Clinical Cancer Genomics - Joanne Ngeow and Charis Eng ; 37. Genomics and Infectious diseases: Susceptibility, resistance and anti-microbial therapy-Michaela Fakiola, Wei Lu, Sarra E. Jamieson and Christopher S. Peacock ; 38. Genomic perspectives of clinical immunology- Cornelius L. Verweij ; 39. Genomic applications in Clinical Pediatrics- Vinod Varghese, Sian Morgan and Ian Frayling ; 40. Genetics and Genomics in clinical ophthalmology I: The spectrum of genetic eye disease-Graeme CM Black ; 41. Genetics and Genomics in clinical ophthalmology II: Glaucoma - Roshanak Sharafieh, Anne H. Child and Mansoor Sarfarazi ; 42. Genetics and Genomics in clinical ophthalmology III: Age-Related Macular Degeneration- Mark E. Kleinman and Jayakrishna Ambati ; 43. Genomic applications in audiological medicine- Daphne Karfunkel-Doron, Zippora Brownstein and Karen B. Avraham ; 44. Genetics and Genomics of skin diseases I: Diseases of the epidermis: eczema, psoriasis- Paul Bowen ; 45. Genetics and Genomics of skin diseases II: Genomics of pigmentation and skin cancer- Eugene Healy ; 46. The genetic and genomic practice of reproductive medicine- Dhavendra Kumar ; 47. Stem cell Genomics - Kyle M. Loh & Bing Lim & Lay Teng Ang ; 48. Genomic applications in critical care medicine- Mathew Frise, Charles Hinds & Julian Knight ; 49. Targeted molecular therapy- Mark Davies & Julian Sampson ; 50. Glossary for genetic and genomic medicine- terms, definitions and phrases- Dhavendra Kumar ; Index

Read more less

Book SynopsisThoroughly updated and revised, this new edition of the classic clinical text provides a comprehensive review of physical measurements used in the clinical evaluation of neonates, children, and adults presenting with dysmorphic features, structural anomalies, or genetic syndromes. It has been formatted as a practical manual that can be carried to the clinic or ward for an assessment of physical features and measurements.Trade Review"This is a high quality book with useful information presented in a well thoughtout and logical sequence. The handbook format provides an advantage over similar publications, allowing practitioners to carry it in the field. It provides a simple approach to areas such as craniometrics with enough detail to make it a great clinical tool." --Doody's "Very few books can compare to this work. This is clearly a must have for all observers of human morphology and the variances seen in human growth and development. ...the authors have outdone themselves with this update." Weighted Numerical Score: 100 - 5 Stars! --Doody's Health Sciences Book ReviewTable of Contents1. Introduction ; 2. Measurement ; 3. Proportional Growth and Normal Variants ; 4. Height and Length ; 5. Weight ; 6. Head Circumference (Occipitofrontal Circumference, OFC) ; 7. Craniofacies ; 8. Limbs ; 9. Chest and Trunk ; 10. Genitalia ; 11. Skin and Hair ; 12. Dermatoglyphics and Trichoglyphics ; 13. Use of Radiographs for Measurement ; 14. Developmental Data ; 15. Prenatal Ultrasound Measurements ; 16. Postmortem Organ Weights ; 17. Measurements for Specific Syndromes

Read more less

Book SynopsisKnowledge of the genetic basis of human diseases is growing rapidly, with important implications for pre-conceptional, prenatal, and predictive testing. While new genetic testing offers better insight into the causes of and susceptibility for heritable diseases, not all inherited diseases that can be predicted on the basis of genetic information can be treated or cured. Should we test everyone who wants to know his or her genetic status, even when there are no possibilities for treatment? What is the role of the right-not-to-know? Do we test children for adult onset disorders because the parents just have to know or do we respect the children''s right to choose when they are older? Do we allow commercial companies to offer genetic tests directly to consumers without the proper oversight regarding what the test results will mean? By using a creative approach that focuses on a single extended family as a case example to illustrate each chapter''s key point, the authors elucidate ethical issues arising in the genetics clinic and laboratory surrounding many timely issues, including: prenatal and pre-implantation genetic diagnosis assisted reproductive technologies incidental findings in genetic testing gene patenting testing children for adult onset disorders direct to consumer testing Ethical Dilemmas in Genetic Counseling: Principles through Case Scenarios is essential reading for anyone interested in the ethical issues surfacing in common genetics practice. Written exclusively by genetic counselors, it makes a significant contribution to the field of ethics in genetics and thus will appeal not only to genetic counselors but to physicians, nurses, and all those concerned with bioethics and social science.Trade ReviewThis collection of essays is sure to be a welcome addition to the library of anyone interested in genetics and genetics counselling. * Lauren L Baker, BA (Saint Louis University), Doody's Notes *Table of ContentsChapter 1: Introduction to Clinical Ethics - Rebecca R. Anderson ; Chapter 2: The (micro) Array of Options for Preconceptional and Prenatal Testing - Daragh Conrad and Christy ; Stanley ; Chapter 3: The "ART" of Assisted Reproductive Technologies - Sonja Eubanks Higgins ; Chapter 4: Testing Children for Adult Onset Conditions - Dawn Allain ; Chapter 5: These are Not the Genes You're Looking For: Incidental Findings Identified as a Result of Genetic Testing - Curtis Coughlin II ; Chapter 6: Is That a Threat or a Promise? Direct-to-Consumer Marketing of Genetic Testing - Laura Hercher ; Chapter 7: Genetics and Patent Law - Rebecca R. Anderson ; Chapter 8: Ethical Issues in Genetic and Genomic Research - Dawn Allain and Kelly Ormond

Read more less

Book SynopsisOutlines the laboratory diagnosis of a selected number of diseases which have relatively high incidence and existing screening programs.

Read more less

Book SynopsisA groundbreaking medical and social history of a devastating hereditary neurological disorder once demonized as “the witchcraft disease”Trade ReviewWinner of the 2009 American Medical Writers Association Medical Book Award in the Healthcare Professionals (non-physician) category, given by the American Medical Writers Association.“Wexler provides an accessible account of a disease in history. A richness of context gives her study its strength and character.”—Charles E. Rosenberg, Harvard University“This is a remarkable story of ‘St. Vitus' Dance’ (Huntington's Chorea) from many perspectives: personal, historical and social. Its meticulous history, drawn from archives and personal experience details how this late-onset hereditary disease was viewed not only medically but personally and socially by family members, neighbors and friends of afflicted individuals. This is a must read for anyone interested in the social history and policy surrounding hereditary disease.”—Garland Allen, Washington University in St. Louis“This book is an engaging chronicle of how the lived experience of illness in a family and community transforms over centuries into an intensely monitored and medicalized hereditary disease. Wexler does what historians do best: she folds what we take now to be a straightforward phenomenon, Huntington’s disease, back into the story of its making. By doing so, she tells us something profound about how we imagine ourselves and how we are connected to one another.”—Rosemarie Garland-Thomson, author of Extraordinary Bodies: Figuring Physical Disability in American Literature and Culture“A brave and pioneering work.”—Daniel Kevles, author of In the Name of Eugenics: Genetics and the Uses of Human Heredity “Alice Wexler has once again accomplished the near impossible by writing a fascinating academic page-turner. Filled with truth and brilliance throughout, The Woman Who Walked into the Sea is an amazing book that leaves the reader not only better informed, but materially enriched, moved by the experience, and not wanting it to end.”—Carole Browner, University of California, Los Angeles

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less